Drug Profile
Monoclonal antibody GA6
Latest Information Update: 17 Nov 2003
Price :
$50
*
At a glance
- Originator Pharmacia Corporation; Unknown
- Developer Pharmacia Corporation
- Class Monoclonal antibodies
- Mechanism of Action Selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arterial thrombosis; Coronary disorders
Most Recent Events
- 17 Nov 2003 Discontinued - Preclinical for Arterial thrombosis in USA (IV)
- 17 Nov 2003 Discontinued - Preclinical for Coronary disorders in USA (IV)
- 02 Sep 1998 No-Development-Reported for Arterial thrombosis in USA (IV)